UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 109

Sortiert nach

Abstract 3304: 17β-hydroxysteroid dehydrogenase type 1 is under negative regulation from miR-210 and 518c in breast cancer

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.3304-3304

2014

Volltextzugriff (PDF)

17β-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer

Cancer research (Chicago, Ill.), 2006-12, Vol.66 (23), p.11471-11477

2006

Volltextzugriff (PDF)

YAP1 is a potential biomarker for cetuximab resistance in head and neck cancer

Oral oncology, 2014-09, Vol.50 (9), p.832-839

2014

Volltextzugriff (PDF)

17β-Hydroxysteroid dehydrogenase type 14 is a predictive marker for tamoxifen response in oestrogen receptor positive breast cancer

PloS one, 2012, Vol.7 (7), p.e40568-e40568

2012

Volltextzugriff (PDF)

CD-Sens and Component Resolved Diagnostics In Diagnosing Hazelnut Allergy

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014-02, Vol.133 (2), p.AB111-AB111

2014

Volltextzugriff (PDF)

Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer

Oncotarget, 2017-05, Vol.8 (18), p.30552-30562

2017

Volltextzugriff (PDF)

Ratio of 17HSD1 to 17HSD2 Protein Expression Predicts the Outcome of Tamoxifen Treatment in Postmenopausal Breast Cancer Patients

Clinical cancer research, 2009-05, Vol.15 (10), p.3610-3616

2009

Volltextzugriff (PDF)

Noxa in colorectal cancer: a study on DNA, mRNA and protein expression

Oncogene, 2003-07, Vol.22 (30), p.4675-4678

2003

Volltextzugriff (PDF)

Bax Expression Decreases Significantly From Primary Tumor to Metastasis in Colorectal Cancer

Journal of clinical oncology, 2002-02, Vol.20 (3), p.811-816

Jansson, A.

2002

Volltextzugriff (PDF)

17Beta-hydroxysteroid dehydrogenase enzymes and breast cancer

Journal of steroid biochemistry and molecular biology, 2009-03, Vol.114 (1), p.64-67

Jansson, Agneta

2009

Volltextzugriff (PDF)

Abstract 2286: Medroxyprogesterone acetate induces expression of 17βHSD1 and 17βHSD5 in the progesterone receptor positive breast cancer cell lines T47D and MCF7

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.2286-2286

Jansson, Agneta

2011

Volltextzugriff (PDF)

Progesterone and levonorgestrel regulate expression of 17βHSD-enzymes in progesterone receptor positive breast cancer cell line T47D

Biochemical and biophysical research communications, 2012-05, Vol.422 (1), p.109-113

2012

Volltextzugriff (PDF)

Abstract A52: The microRNA control of 17β-hydroxysteroid dehydrogenase type 1 and 2 in breast cancer

Molecular cancer research, 2016-02, Vol.14 (2_Supplement), p.A52-A52

2016

Volltextzugriff (PDF)

Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer

British journal of cancer, 2016-02, Vol.114 (3), p.248-255

2016

Volltextzugriff (PDF)

The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer

Oncotarget, 2017-09, Vol.8 (37), p.62183-62194

2017

Volltextzugriff (PDF)

Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-[alpha]-negative breast cancer

British journal of cancer, 2016-02, Vol.114 (3), p.248

2016

Volltextzugriff (PDF)

C–X–C ligand 10 and C–X–C receptor 3 status can predict tamoxifen treatment response in breast cancer patients

Breast cancer research and treatment, 2014-05, Vol.145 (1), p.73-82

2014

Volltextzugriff (PDF)

Ki-67 expression in relation to clinicopathological variables and prognosis in colorectal adenocarcinomas

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 1997-07, Vol.105 (7-12), p.730-734

1997

Volltextzugriff (PDF)

Expression patterns of 17β-hydroxysteroid dehydrogenase 14 in human tissues

Hormone and metabolic research, 2012-12, Vol.44 (13), p.949

2012

Volltextzugriff (PDF)

Abstract B251: Androgen receptor expression can predict benefit of tamoxifen treatment in patients with ER negative breast cancer

Molecular cancer therapeutics, 2013-11, Vol.12 (11_Supplement), p.B251-B251

2013

Volltextzugriff (PDF)

Barrier and mechanical properties of modified starches

Cellulose (London), 2005-08, Vol.12 (4), p.423-433

2005

Volltextzugriff (PDF)

Diet, Growth, and the Risk for Type 1 Diabetes in Childhood

Diabetes care, 2004-12, Vol.27 (12), p.2784-2789

2004

Volltextzugriff (PDF)

Abstract 3142: Expression of C-X-C motif chemokine 10 (CXCL10) in breast cancer

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.3142-3142

2011

Volltextzugriff (PDF)

Abstract 3141: Analysis of the endocrine treatment predictive protein HOXB13 in premenopausal breast cancer

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.3141-3141

2011

Volltextzugriff (PDF)

Predictive relevance of HOXB13 protein expression for tamoxifen benefit in breast cancer

Breast cancer research : BCR, 2010-01, Vol.12 (4), p.R53-R53, Article R53

2010

Volltextzugriff (PDF)

1 – 25 von 109

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(100)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(68)
Life Sciences & Biomedicine
(65)
Female
(45)
Humans
(44)
Biological And Medical Sciences
(31)
Medical Sciences
(23)
Medicin Och Hälsovetenskap
(23)
Medicine
(23)
Male
(22)
Medicin
(21)
Oncology
(21)
Animals
(16)
Middle Aged
(15)
Tumors
(15)
Breast Cancer
(13)
Immunohistochemistry
(13)
Prognosis
(12)
Aged
(11)
Fundamental And Applied Biological Sciences. Psychology
(10)
Pregnancy
(10)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Abstract 3304: 17β-hydroxysteroid dehydrogenase type 1 is under negative regulation from miR-210 and 518c in breast cancer

17β-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer

YAP1 is a potential biomarker for cetuximab resistance in head and neck cancer

17β-Hydroxysteroid dehydrogenase type 14 is a predictive marker for tamoxifen response in oestrogen receptor positive breast cancer

CD-Sens and Component Resolved Diagnostics In Diagnosing Hazelnut Allergy

Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer

Ratio of 17HSD1 to 17HSD2 Protein Expression Predicts the Outcome of Tamoxifen Treatment in Postmenopausal Breast Cancer Patients

Noxa in colorectal cancer: a study on DNA, mRNA and protein expression

Bax Expression Decreases Significantly From Primary Tumor to Metastasis in Colorectal Cancer

17Beta-hydroxysteroid dehydrogenase enzymes and breast cancer

Abstract 2286: Medroxyprogesterone acetate induces expression of 17βHSD1 and 17βHSD5 in the progesterone receptor positive breast cancer cell lines T47D and MCF7

Progesterone and levonorgestrel regulate expression of 17βHSD-enzymes in progesterone receptor positive breast cancer cell line T47D

Abstract A52: The microRNA control of 17β-hydroxysteroid dehydrogenase type 1 and 2 in breast cancer

Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer

The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer

Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-[alpha]-negative breast cancer

C–X–C ligand 10 and C–X–C receptor 3 status can predict tamoxifen treatment response in breast cancer patients

Ki-67 expression in relation to clinicopathological variables and prognosis in colorectal adenocarcinomas

Expression patterns of 17β-hydroxysteroid dehydrogenase 14 in human tissues

Abstract B251: Androgen receptor expression can predict benefit of tamoxifen treatment in patients with ER negative breast cancer

Barrier and mechanical properties of modified starches

Diet, Growth, and the Risk for Type 1 Diabetes in Childhood

Abstract 3142: Expression of C-X-C motif chemokine 10 (CXCL10) in breast cancer

Abstract 3141: Analysis of the endocrine treatment predictive protein HOXB13 in premenopausal breast cancer

Predictive relevance of HOXB13 protein expression for tamoxifen benefit in breast cancer

Suchergebnisse filtern